January 16, 2016

BUFFALO, N.Y., Jan. 14, 2016 — Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaboration agreement with the New York Center for Nanomedicine Research (NYCNMR) to co-market their nanotechnology services to global pharmaceutical and biotechnology clients.

Posted in Press Release
December 16, 2015

Published by 12/16/2015 Screen Shot 2015-12-16 at 9.39.43 AM   BUFFALO, N.Y. (WIVB) – Western New York is quickly becoming a hub for medical research, including in the field of nano-technology.  The New York Center for Nanomedicine Research is part of the Buffalo-Niagara Medical Campus. This small group of researchers is changing the way we use medicine, and they’re bringing economic growth to the region. Co-Founder and CEO, ScottPatrick Sellitto said, nano-medicine is, “the new black.” He says this and NYCNMR is making Buffalo trendy. What makes nanomedicine unique, is its ability to make bad drugs good. Sellito said, “Various cancer treatments are given, and if the cancer doesn’t kill you, the drugs probably will.” By using nano-technology to change the structure of these active drugs,  Sellito said they become safer, and make you less sick. Co-Founder, Dr. Stanley Schwartz, said, “Nano means one-billionth

Posted in News
October 2, 2015

  The New York Center of Nanomedicine Research was acknowledged by Business First on October 2, 2015, for bringing the promise of contracts exceeding $2 million over the next 18 months to the Western New York region. Screen Shot 2015-10-02 at 3.27.51 PM Screen Shot 2015-10-02 at 3.27.05 PM

Posted in News
September 30, 2015

Just months after an official launch this summer at the national Bio conference in Philadelphia, the New York Center for Nanomedicine Research Inc. has grown to nearly a dozen staffers in Buffalo and expects to end its first six months of operation with more than $1 million in revenue.

Housed at the University at Buffalo’s Clinical and Translational Research Center on the Buffalo Niagara Medical Campus, the company is working with pharmaceutical companies, academic researchers and corporate clients on commercialization efforts by applying nanotechnology to clinical applications.

Read the full article here.

Posted in News